Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL/CAELYX) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group
(Q43582734)
scientific article published in May 2001
scientific article published in May 2001
Language:
other details
description | scientific article published in May 2001 |
External Links
(P356) |
10.1016/S0959-8049(01)00050-8
|
(P698) |
11313175
|